|
RASAL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.927580E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.421900E-02 |
| Normal-vs-Stage2 |
2.878200E-01 |
| Normal-vs-Stage3 |
2.861400E-01 |
| Normal-vs-Stage4 |
5.944000E-02 |
| Stage1-vs-Stage2 |
7.279000E-01 |
| Stage1-vs-Stage3 |
6.228200E-01 |
| Stage1-vs-Stage4 |
5.018200E-01 |
| Stage2-vs-Stage3 |
9.467000E-01 |
| Stage2-vs-Stage4 |
4.169000E-01 |
| Stage3-vs-Stage4 |
3.631000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.808000E-02 |
| Normal-vs-AfricanAmerican |
2.048600E-01 |
| Normal-vs-Asian |
1.042440E-01 |
| Caucasian-vs-AfricanAmerican |
9.267400E-01 |
| Caucasian-vs-Asian |
4.847200E-01 |
| AfricanAmerican-vs-Asian |
4.441400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.031800E-02 |
| Normal-vs-Female |
6.514400E-01 |
| Male-vs-Female |
1.593790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.999800E-02 |
| Normal-vs-Extreme_Weight |
7.984000E-02 |
| Normal-vs-Obese |
5.928800E-01 |
| Normal-vs-Extreme_Obese |
2.473000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.180600E-01 |
| Normal_Weight-vs-Obese |
2.066400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.886600E-01 |
| Extreme_Weight-vs-Obese |
1.812580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.819400E-01 |
| Obese-vs-Extreme_Obese |
5.428400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.340400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.783000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.056400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.237700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.071000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.144000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.744050E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.678900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.333600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.829800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.160000E-01 |
| Normal-VS-Type2 PRCC |
1.374890E-04 |
| Normal-VS-KIRP CIMP |
5.903200E-01 |
| Normal-VS-Unclassified PRCC |
5.682800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.79640000000014E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.243600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.282020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.135350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.389800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
7.182000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.078930E-03 |
| Normal-vs-N1 |
8.720800E-01 |
| Normal-vs-N2 |
5.201200E-01 |
| N0-vs-N1 |
8.352000E-02 |
| N0-vs-N2 |
4.580200E-01 |
| N1-vs-N2 |
7.484200E-01 |
|
|
